Automotive &amp; Mobility

Communications

Consumer Products

Financial Services

Healthcare

Media

Retail

Social Impact

Technology

Brand Strategy

Brand Strategy, Design &amp; Performance

Client Collaborative

Connected World

Content &amp; Asset Management

Corporate Venture Building

CX Strategy

CX Strategy, Design &amp; Performance

Design &amp; Development

Design &amp; Performance

DesignOps

Elevated Loyalty

Engage at the Edge

Growth Strategy

Industrial Design

Innovation Strategy

Membership &amp; Loyalty

Organization Design

Product Design &amp; Delivery

Product Innovation

Product Innovation, Design &amp; Development

Service Design

Startup Growth

Sustainability

Bangalore

Barcelona

Delhi

frog Innovation Team

Gothenburg

London

Lyon

Madrid

Malmö

Mexico City

Milan

Munich

New York

Paris

San Francisco

Singapore

Stockholm

Sydney

frog-cap-invent-logo

frog-Cap-Invent-logo

global

france

Personal protective equipment (PPE) engineered to ​​kill pathogens

Pioneering UV-C EnhancedRespiratory Protection

24_case-study_xcmr_header-png

24_Case_Study_XCMR_header.png

Integrating health and harmony

23_case-study_xcmr_big_image

23_Case-Study_XCMR_big_image

23_case-study_xcmr_big_image_2

23_Case-Study_XCMR_big_image_2

normal

XCMR presented frog with powerful UV-C technology for pathogen inactivation. The challenge was to make it easily usable and fit modern expectations of technology in stressful, highly contaminated environments.  

Challenge

Innovating UV-C Solutions

The modular system features a transparent facial mask that enables clearer communication, interchangeable UV-C reactor pods that target specific pathogens and a hot-swappable battery that enables uninterrupted wear.

Solution

Optimizing pathogen defense

frog and XCMR developed an innovative new class of UV-C enabled respiratory protection devices that readily inactivates​ pathogens, enabling ​​​individuals​​​ to work​ safely​ in high-risk bioaerosol environments.

Outcomes

A modular approach

Project highlights

Humanizing respiratory protection

23_case-study_xcmr_big_image_3

23_Case-Study_XCMR_big_image_3

23_case-study_xcmr_image_1

23_Case-Study_XCMR_image_1

23_case-study_xcmr_image_right_2

23_Case-Study_XCMR_image_right_2

23_case-study_xcmr_image_right_1

23_Case-Study_XCMR_image_right_1

<a href="https://www.frog.co/contact" target="_blank">Get in touch</a> with frog to start shaping the next generation of experiences for people and planet.

frog-icon-healthcare-2

frog-icon-Healthcare

Designing for health and safety

Revolutionizing Testing at the Point-of-Need  – MeMed

Breathing Life into Lumen

Translating breakthrough science for personalized care

Unleashing CRISPRfor the Greater Good

24_case_study_mammoth_header

24_Case_Study_Mammoth_Header

From discoveries to patients

24_case_study_mammoth_2

24_Case_Study_Mammoth_2

24_case_study_mammoth_4

24_Case_Study_Mammoth_4

24_case_study_mammoth_3

24_Case_Study_Mammoth_3

Mammoth sought to create CRISPR-powered diagnostic devices with the versatility to detect multiple pathogens at once, while remaining low-cost, simple and portable for use in homes and at the Point-of-Care (POC).  This meant translating foundational scientific discoveries into a wide range of beautifully crafted, trusted and accessible products with unique solutions for integrating technical elements.

Translating innovation 

frog helped Mammoth conduct multiple rounds of user research to discover patient and practitioner needs. Prototype devices were built around how real people use diagnostics and POC workflows. This data informed everything from devices’ workflows, physical and digital features, engineering architecture, to formal expression of brand identity.

Prototyping user research

By setting a clear direction for teams to follow, frog helped enable Mammoth’s vision to democratize lab-quality diagnostics. Together, we defined a set of north star products and brand strategy in the healthcare space, making its  ambition clear for both the product teams and potential partners. 

A path to products

From lab to lap

How two compact CRISPR-tech devices can unlock  personalized care across the testing spectrum 

Two progressive prototypes

24_case_study_mammoth_5

24_Case_Study_Mammoth_5

24_case_study_mammoth_6

24_Case_Study_Mammoth_6

24_case_study_mammoth_7

24_Case_Study_Mammoth_7

To learn more about Mammoth's innovations, visit <a href="https://mammoth.bio" target="_blank">mammoth.bio</a>.

Inspiring, progressive biotech

Bringing Innovative Med-Tech to Market with Ambu

Putting Atmospheric CO2 to Work

connected-world-case-study-grid3-2

connected-world-case-study-Grid3

Aircapture’s system sequesters CO2 from ambient air and puts it directly into commercial use

23_frog_aircapture_header-3

23_frog_Aircapture_header-3

Reinventing the carbon economy

_23_frog_aircapture_01_scene

_23_frog_Aircapture_01_scene

Clearing the air

We’re proud of our partnership with Aircapture and look forward to developing many more innovative solutions in the fight against climate change.

23_frog_volvo_harnessing-data-for-leaner-and-greener-future-of-mobility-icon

Creating and scaling a circular carbon economy 

Build intelligent offerings, ecosystems and transformational solutions with frog.

Discover the New Connected World Offering

outline

connected_world-comp_video5-2

connected_world-comp_video5

Using Data for Reliable Power Generation 

Revolutionizing Testing at the Point-of-Need

memed_9_03

MEMED_9_03

memed_9-mobile

MEMED_9-mobile

memed_9-tablet

MEMED_9-tablet

The WHO has identified antimicrobial resistance resulting from the overuse of antibiotics as one of the greatest challenges facing modern medicine. To tackle that challenge, med-tech company MeMed developed the pioneering ImmunoXpert lab test, which analyzes patients’ immune responses to distinguish between bacterial and viral infections, helping physicians to prescribe antibiotics more accurately and less frequently.
In order to maximize the value and accessibility of the ImmunoXpert test (now called the MeMedBV®), MeMed turned to frog to help them define and design a revolutionary immunoassay platform that could automatically perform ImmunoXpert diagnostics at the point of care in just 15 minutes, providing results where and when they are needed the most. frog&#8217;s<a href="https://www.frog.co/designmind/real-transformation-and-disruption-takes-convergent-design"> convergent design</a> approach and multidisciplinary team was key to the success of this project and the holistic integration of the platform&#8217;s product, service and digital experiences.

memed_hero_desktop

MeMed_Hero_Desktop

memed_2-new-2

MEMED_2-new

"The MeMed Key® is far greater than the sum of its parts. It is a perfect storm of engineering, design and product converging in a never-ending desire to perfect every fine detail. This was an enlightening experience of how far true collaboration between a group of talented individuals can reach."

The challenges involved in the project were immense and multifaceted. The platform would have to meet the practical needs of care providers in GP offices, nursing homes, hospitals and urgent care facilities, while also meeting the testing standards of central lab technicians. Through a process of immersive research in various point of care contexts, the frog team helped to identify the core user needs and product requirements that would drive design and technology ideation.
After initial research, frog planned and orchestrated iterative design workshops that brought MeMed, frog, the engineering and manufacturing partner, the consumables manufacturer and chemicals experts together into a collaborative process throughout the development cycle. Working together, the team was able to develop product architecture and experience concepts informed by both functional and aesthetic criteria, and which continuously evolved according to ongoing explorations of the system’s UI and data visualizations. Eventually, a semi-functional model of the MeMed Key® system was built and tested in Italy and Israel, validating the complete product and experience from process start and patient data insertion to scanning and result output.

	Global		EN
	France		FR

	Global		EN
	France		FR